Tylosin Market To Generate a Significant Revenue of US$ 0.3 Billion Threshold By 2026 Globally | CAGR: 1.2%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Global Tylosin Market, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), by Application (Felines, Canines, and Livestock), by Route of Administration (Oral and Injectable), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 379.0 million in 2017 and is projected to exhibit a CAGR of 1.2% over the forecast period (2018 – 2026).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2061
The global tylosin market is expected to be driven by factors such as availability of wide number of therapeutic options and dosage strengths, antimicrobial efficacy and effectiveness, high prevalence of infectious diseases, and rising demand for livestock. Tylosin is available under brand names such as Tylan (Tylosin Phosphate) by Elanco, Tylovet (Tylosin Phosphate) by Huvepharma, Tylan Soluble (Tylosin Tartrate) by Elanco, and others. There is rising demand for antibiotics against infection in livestock. This is attributed to rising demand for healthy livestock for human consumption. Antibiotics such as tylosin are used against mycoplasmosis in several animals such as chickens, turkeys, pigs, and calves. Oral administration of tylosin is possible at required dosage to prevent above mentioned infection and to grow healthy livestock. Tylosin is offered by various manufacturers such as Elanco Animal Health, Zoetis, Tairui Pharmaceuticals, AdvaCare Pharma, and others in various forms such as active pharmaceutical ingredient and solid dosage form, and it is generally available in veterinary soluble powder and granule forms.
The U.S. Food & Drug Administration (FDA) approved new combination uses of Zoetis feed additives ACTOGAIN 45 (ractopamine hydrochloride) and Engain (ractopamine hydrochloride) in 2015. ACTOGAIN 45 can be used with Rumensin (monensin USP) plus Tylovet 100 (tylosin phosphate).
Browse 17 Market Data Tables and 20 Figures spread through 147 Pages and in-depth TOC on Tylosin Market, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), By Application (Felines, Canines, and Livestock), By Route of Administration (Oral and Injectable), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026
To know the latest trends and insights prevalent in the tylosin Market Press Release, click the link below: http://bit.ly/2WRdq4p
Various strategies such as participation in events and meets, raising awareness about animal health, and marketing activities are being adopted by manufacturers, in order to showcase their products. For instance, Huvepharma participated in Respiratory Health Seminar for Pig Practitioners that took place in Belgium in 2017. Moreover, the company held its 5th European seminar: Insights on Nutrition and Health of High Performing Animals in June 2018. Furthermore, in January 2018, Huvepharma acquired AgriLabs with the objective of expanding the company’s presence in the U.S. Moreover, in 2015, Elanco released an eight-point antibiotic stewardship plan to outline global actions for the company, in order to ensure long-term access to antibiotics for people and animals.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/2061
Key Takeaways of the Tylosin Market:
- The global tylosin market is expected to exhibit a CAGR of 1.2% over the forecast period (2018 – 2026), as leading manufacturers are providing various products
- North America and Europe are expected to retain their dominant position in the tylosin market over the forecast period. This is owing to significant use of tylosin in livestock industry and presence of leading manufacturers in these regions.
- Key players operating in the global tylosin market include Zoetis, Inc., Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, and Elanco Animal Health
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2061
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire